January 18, 2012
CPSS / IOSCO Report on OTC Trade Reporting
The final report from the CPSS / IOSCO has been published, the original source page is here the full PDF is here. Highlights include:
- Minimum data reporting requirements: The Task Force recommends that, at a minimum, transaction-level data be reported to TRs and that such data include at least transaction economics, counterparty information, underlier information, operational data and event data.
- Methodology and mechanism for aggregation of data: As mechanisms for aggregation of data, the report recommends creation of a system of legal entity identifiers (LEIs), continued international consultation regarding implementation of LEIs, and international work to develop an international product classification system for OTC derivatives.
- Development of a standard international product classification system: The Task Force recommends that CPSS-IOSCO or the FSB make a public statement calling for timely industry-led development, in consultation with authorities, of a standard product classification system that can be used as a common basis for classifying and describing OTC derivative products.
- Annex 1:Current state of OTC derivatives reporting and access to information for the major existing Trade Repositories (TRs)
- Annex 2: Illustrative list of potential data fields for OTC derivatives
- Annex 3: Information regarding possible implementation of a system of legal entity identifiers (LEIs)
The report isn’t a regulatory rule or mandate, but the summation of a large group of parties from central banks and other organisations. The report doesn’t appear to say who should deliver the data to TRs – so whether a CCP or trading platform can deliver the data to a TR on behalf of parties isn’t discussed.
Sep. 15, 2022
Tradefeedr Hires Alexis Fauth as Head of Data Science and Client Analytics
Sep. 06, 2022
Siege FX announces the launch of NetFix
Aug. 02, 2022
OSTTRA and LCH collaborate to reconcile bilateral OTC trade data
Jul. 26, 2022
Sell-side systems in need of upgrade for new risk reality
Jul. 15, 2022